PortfoliosLab logoPortfoliosLab logo
ADEA vs. ANIP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ADEA vs. ANIP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Adeia Inc (ADEA) and ANI Pharmaceuticals, Inc. (ANIP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ADEA achieves a 85.80% return, which is significantly higher than ANIP's 3.47% return. Over the past 10 years, ADEA has outperformed ANIP with an annualized return of 16.91%, while ANIP has yielded a comparatively lower 4.07% annualized return.


ADEA

1D
-2.15%
1M
0.82%
YTD
85.80%
6M
144.66%
1Y
133.63%
3Y*
46.44%
5Y*
42.19%
10Y*
16.91%

ANIP

1D
0.04%
1M
0.99%
YTD
3.47%
6M
1.60%
1Y
31.49%
3Y*
18.03%
5Y*
18.57%
10Y*
4.07%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ADEA vs. ANIP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ADEA
Adeia Inc
85.80%25.22%14.75%33.53%92.17%-8.65%16.55%4.53%-21.13%-43.16%
ANIP
ANI Pharmaceuticals, Inc.
3.47%42.80%0.25%37.06%-12.70%58.68%-52.91%36.98%-30.15%6.32%

Correlation

The correlation between ADEA and ANIP is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (10Y)
Calculated over the trailing 10-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Nov 20, 2003

0.21

The correlation between ADEA and ANIP shifts across timeframes, from 0.10 (1 year) to 0.24 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ADEA:

$3.65B

ANIP:

$1.76B

EPS

ADEA:

$1.08

ANIP:

$4.26

PE Ratio

ADEA:

29.57

ANIP:

19.17

PEG Ratio

ADEA:

2.06

ANIP:

0.13

PS Ratio

ADEA:

7.84

ANIP:

1.86

PB Ratio

ADEA:

7.81

ANIP:

3.13

Total Revenue (TTM)

ADEA:

$460.49M

ANIP:

$923.71M

Gross Profit (TTM)

ADEA:

$312.21M

ANIP:

$486.11M

EBITDA (TTM)

ADEA:

$235.56M

ANIP:

$234.71M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ADEA vs. ANIP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADEA
ADEA Risk / Return Rank: 8989
Overall Rank
ADEA Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
ADEA Sortino Ratio Rank: 8787
Sortino Ratio Rank
ADEA Omega Ratio Rank: 9090
Omega Ratio Rank
ADEA Calmar Ratio Rank: 8888
Calmar Ratio Rank
ADEA Martin Ratio Rank: 9090
Martin Ratio Rank

ANIP
ANIP Risk / Return Rank: 6767
Overall Rank
ANIP Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
ANIP Sortino Ratio Rank: 7171
Sortino Ratio Rank
ANIP Omega Ratio Rank: 6767
Omega Ratio Rank
ANIP Calmar Ratio Rank: 6666
Calmar Ratio Rank
ANIP Martin Ratio Rank: 6262
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ADEA vs. ANIP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Adeia Inc (ADEA) and ANI Pharmaceuticals, Inc. (ANIP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ADEAANIPDifference
Sharpe ratioReturn per unit of total volatility

+1.27

Sortino ratioReturn per unit of downside risk

+1.07

Omega ratioGain probability vs. loss probability

1.40

1.19

+0.21

Calmar ratioReturn relative to maximum drawdown

3.86

1.10

+2.76

Martin ratioReturn relative to average drawdown

10.97

2.06

+8.91

ADEA vs. ANIP - Sharpe Ratio Comparison

The current ADEA Sharpe Ratio is 2.16, which is higher than the ANIP Sharpe Ratio of 0.89. The chart below compares the historical Sharpe Ratios of ADEA and ANIP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ADEA vs. ANIP - Drawdown Comparison

The maximum ADEA drawdown since its inception was -80.75%, smaller than the maximum ANIP drawdown of -98.81%. Use the drawdown chart below to compare losses from any high point for ADEA and ANIP.


Loading charts...

Drawdown Indicators


ADEAANIPDifference

Max Drawdown

Largest peak-to-trough decline

-80.75%

-98.81%

+18.06%

Max Drawdown (1Y)

Largest decline over 1 year

-34.81%

-28.66%

-6.15%

Max Drawdown (3Y)

Largest decline over 3 years

-34.81%

-28.66%

-6.15%

Max Drawdown (5Y)

Largest decline over 5 years

-38.97%

-59.38%

+20.41%

Max Drawdown (10Y)

Largest decline over 10 years

-73.66%

-72.96%

-0.70%

Current Drawdown

Current decline from peak

-4.91%

-81.85%

+76.94%

Average Drawdown

Average peak-to-trough decline

-37.82%

-79.39%

+41.57%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.25%

15.33%

-3.08%

Volatility

ADEA vs. ANIP - Volatility Comparison

Adeia Inc (ADEA) has a higher volatility of 23.40% compared to ANI Pharmaceuticals, Inc. (ANIP) at 9.14%. This indicates that ADEA's price experiences larger fluctuations and is considered to be riskier than ANIP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ADEAANIPDifference

Volatility (1M)

Calculated over the trailing 1-month period

23.40%

9.14%

+14.26%

Volatility (6M)

Calculated over the trailing 6-month period

50.06%

24.38%

+25.68%

Volatility (1Y)

Calculated over the trailing 1-year period

62.21%

35.56%

+26.65%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

62.42%

46.29%

+16.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

56.47%

48.26%

+8.21%

Dividends

ADEA vs. ANIP - Dividend Comparison

ADEA's dividend yield for the trailing twelve months is around 0.63%, while ANIP has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ADEA
Adeia Inc
0.63%1.16%1.43%1.61%0.95%1.06%2.39%4.32%4.35%3.28%1.81%2.67%
ANIP
ANI Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ADEA vs. ANIP - Financials Comparison

This section allows you to compare key financial metrics between Adeia Inc and ANI Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


50.00M100.00M150.00M200.00M250.00M20222023202420252026
104.77M
237.46M
(ADEA) Total Revenue
(ANIP) Total Revenue
Values in USD except per share items

ADEA vs. ANIP - Profitability Comparison

The chart below illustrates the profitability comparison between Adeia Inc and ANI Pharmaceuticals, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%2022202320242025202600
Portfolio components
ADEA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Adeia Inc reported a gross profit of 0.00 and revenue of 104.77M. Therefore, the gross margin over that period was 0.0%.

ANIP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ANI Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 237.46M. Therefore, the gross margin over that period was 0.0%.

ADEA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Adeia Inc reported an operating income of 34.83M and revenue of 104.77M, resulting in an operating margin of 33.3%.

ANIP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ANI Pharmaceuticals, Inc. reported an operating income of 38.89M and revenue of 237.46M, resulting in an operating margin of 16.4%.

ADEA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Adeia Inc reported a net income of 22.77M and revenue of 104.77M, resulting in a net margin of 21.7%.

ANIP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ANI Pharmaceuticals, Inc. reported a net income of 29.49M and revenue of 237.46M, resulting in a net margin of 12.4%.


Frequently Asked Questions


ADEA and ANIP have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ADEA has higher volatility (23.40%) compared to ANIP (9.14%). In terms of maximum drawdown, ADEA dropped -80.75% vs ANIP's -98.81%.

ADEA currently has the higher Sharpe Ratio (2.16 vs 0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ADEA and ANIP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer